Rchr
J-GLOBAL ID:200901018331141210
Update date: Sep. 13, 2024
Fujita Tomoe
フジタ トモエ | Fujita Tomoe
Affiliation and department:
Job title:
Professor
Research field (2):
Pharmaceuticals - chemistry and drug development
, Pharmacology
Research keywords (16):
尿細管分泌
, 有機アニオントランスポータ
, チトクロームP450
, 薬物トランスポータ
, ダイセクション
, 接合尿細管
, カルシウム動態
, カリクレイン分泌
, renal tubular secretion
, organic anion transporter
, cytvhrome P450
, drug transporter
, dissection
, connecting tubule
, calcium imaging
, kallikrein secretion
Research theme for competitive and other funds (18):
- 2021 - 2024 間質性膀胱炎の肥満細胞関連因子は、膀胱知覚亢進に寄与するか
- 2019 - 2023 Potential of amino acid transporter as a marker for inflammation of intestinal mucosa
- 2014 - 2018 Roles of bioactive lipids in regulation of lymphatic plasticity
- 2011 - 2015 Roles of prostanoids in facilitation of lymphangiogenesis and lymph node metastasis
- 2011 - 2013 Examination for genomic biomarkers of intestinal and renal drug transporters aiming for the personalized medicine
- 2009 - 2012 Roles of VEGF type 1 receptor signaling in pathologicalangiogenesis/lymphangiogenesis
- 2008 - 2010 Elucidation of mechanisms for the decrease in kallikrein secretion in isolated renal connecting tubular cells and examination of salt sensitivity on polymorphisms
- 2006 - 2007 健常成人におけるインドキシル硫酸と薬物との尿細管分泌における相互作用の検討
- 2006 - 2007 Study on indoxyl sulfate and drug interactions at renal tubular secretion in healthy volunteers.
- 2005 - 2007 Studies of mechanisms for secretion and synthesis of renal kallikrein, a salt-sensitive factor, on immortalized cell lines and its geneticpolymorlphism
- 2004 - 2006 腫瘍依存性血管新生・リンパ管新生を抑制する遺伝子改変幹細胞移植による分子標的治療
- 2003 - 2006 Roles of humoral and neural factors in angiogenesis and lymphangiogenesis in pathological conditions and their significance in molecular targeting therapy
- 2005 - ラット腎炎モデルおよび低蛋白食条件下における各種薬物代謝酵素および薬物トランスポータ調節機構および薬物動態の検討
- 2004 - 2004 炎症性シグナリング遺伝子を改変した造血幹細胞移値による血管・リンパ管新生の抑制
- 2001 - 2002 Na^+排泄増大因子としてのK^+による腎カリクレイン-キニン系活性化の分子機構
- 2000 - 2002 Roles of inducible cyclooxvgenase-2 in angiogenesis and its significance of therapeutic targets
- 腎尿細管におけるカリクレイン分泌調節の研究
- Study on the mechanism of renal kallikrein secretion
Show all
Papers (59):
-
Keitaro Hayashi, Yoshimasa Nakazato, Motoshi Ouchi, Tomoe Fujita, Hitoshi Endou, Masayuki Chida. Antitumor effect of dimethyl itaconate on thymic carcinoma by targeting LDHA-mTOR axis. Life sciences. 2021. 282. 119847-119847
-
ASUKA MORITA, MOTOSHI OUCHI, KEITARO SATOH, SHUNSUKE KOBAYASHI, MISAO TERADA, HIDEFUMI WAKASHIN, HIROE KON, KEITARO HAYASHI, NAOHIKO ANZAI, AKIRA SHIMIZU, et al. The Effects of Trypsin Inhibitor on Insulin Secretion Using Rat Pancreas in an Organ Bath. In Vivo. 2021. 35. 5. 2551-2558
-
Yuji Kumagai, Tomoe Fujita, Mika Maeda, Yoshinobu Sasaki, Makoto Nagaoka, Jinhong Huang, Toru Takenaka, Masaki Kawai. A Drug-Drug Interaction Study to Evaluate the Effect of TAS-303 on CYP3A Activity in the Small Intestine and Liver. Journal of clinical pharmacology. 2020. 60. 6. 702-710
-
Takuya Yumizaki, Mika Maeda, Tomoe Fujita, Hiroyoshi Kakuyama, Yuji Kumagai. A 3-Part Phase 1 Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DSP-6952 in Healthy Japanese Subjects and Those With ≤3 Spontaneous Bowel Movements per Week. Clinical pharmacology in drug development. 2020. 9. 3. 353-365
-
Naoyuki Otani, Shigeru Toyoda, Masashi Sakuma, Keitaro Hayashi, Motoshi Ouchi, Tomoe Fujita, Naohiko Anzai, Atsushi Tanaka, Koichi Node, Naoto Uemura, et al. Effects of uric acid on vascular endothelial function from bedside to bench. Hypertension research : official journal of the Japanese Society of Hypertension. 2018. 41. 11. 923-931
more...
MISC (85):
-
Motoshi Ouchi, Kenzo Oba, Hideki Suganami, Akihiro Yoshida, Tomoe Fujita, Tatsuya Suzuki, Masahiro Yasutake, Kohei Kaku. This is in reply to the Letter by Kahathuduwa et al. titled “Unaccounted for regression to the mean renders conclusion of article titled ‘Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor Tofogliflozin’ unsubstantiated”. Diabetes, Obesity and Metabolism. 2018. 20. 8. 2041-2042
-
Mika Maeda, Mika Maeda, Mika Maeda, Tomoe Fujita, Hideki Amano, Harue Kohara, Akira Yamazaki, Akira Yamazaki, Takeshi Hirayama, Masakazu Kuroyama, et al. Pharmacokinetics and pharmacodynamics of a single dose of scopolamine ointment applied to the postauricular area in healthy subjects. Japanese Journal of Clinical Pharmacology and Therapeutics. 2018. 49. 53-58
-
大谷 直由, 池田 信人, 李 佩俐, 大内 基司, 藤田 朋恵, 安西 尚彦, 久留 一郎. プロテアソーム阻害薬がモノカルボン酸トランスポーター9蛋白安定性に及ぼす効果. 痛風と核酸代謝. 2017. 41. 1. 141-141
-
中村裕二, 杉山篤, 橋本大哉, 藤田朋恵, 熊谷雄治. 新規キサンチンオキシダーゼ阻害剤トピロキソスタットの日本人健康成人におけるQT/QTc評価試験. 臨床薬理. 2013. 44. Supplement. S231-S231
-
Hideki Amano, Yoshio Mastui, Yoshiya Ito, Fumihiro Ogawa, Tomoe Fujita, Masafumi Shibuya, Yuji Kumagai, Masataka Majima. ROLES OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1 SIGNALING IN COMPENSATORY CONTRALATERAL LUNG GROWTH AFTER UNILATERAL PNEUMONECTOMY. RESPIROLOGY. 2013. 18. 38-38
more...
Books (2):
-
健康管理と臨床検査-早期診断を目指して-
宇宙堂八木書店 2005
-
H.pylori時代の消化性潰瘍の治療
日本メディカルセンター 2000
Professional career (1):
Association Membership(s) (6):
日本薬学会
, American Society for Clinical Pharmacology and Therapeutics (ASCPT)
, 日本臨床薬理学会
, 日本薬理学会
, 日本内科学会
, American Society for Clinical Pharmacology and Therapeutics (ASCPT)
Return to Previous Page